Author: Vanessa Ngan, Staff Writer, 2003.

What is neurofibromatosis?

Neurofibromatosis (NF) is a genetic disorder that affects the bone, soft tissue, skin and nervous system. It is classified into 2 distinct types, neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2). NF1 occurs in about 1 in 3000 births whilst NF2 only occurs in about 1 in 50,000 births.

NF1, also known as von Recklinghausen disease, is characterised by the presence of:

NF2, also known as bilateral acoustic neurofibromatosis, is characterised by multiple tumours and lesions on the brain and spinal cord. Tumours growing on the auditory nerves that lead to hearing loss is usually the first symptom of the disease. Often this is not apparent until the late teens or early 20's.

What causes neurofibromatosis?

NF1 and NF2 occur as a result of defects in different genes . NF1 is caused by a mutation on a gene located on chromosome 17 and NF2 on chromosome 22. The mutated gene can be inherited from a parent who has NF or in some cases you could be the founder of a spontaneously mutated gene. A parent with NF has a 50% chance of passing the gene on to each of their children.

What are the signs and symptoms of neurofibromatosis?

The extent and severity of manifestations of NF vary greatly from person to person and varies within the same family.

Although isolated café-au-lait spots can be found in many people without NF, individuals with more than 5 of these have a good chance of also having NF1, particularly if they appear on the skin within the first 5 years of life. More than 5 café-au-lait spots are found in 1.8% of newborns, 25-40% of children and 14% of adults with NF1. Freckling under the armpits is a clear sign of NF1.

After puberty, Lisch nodules are present in 97-100% of patients with NF1. Clinically, they do not cause any problems but help to confirm diagnosis.

There are basically 4 types of neurofibromas found in NF1:

See more images of neurofibromatosis ...

The severity of cutaneous involvement in NF1 is not an indicator of the extent of the disease as internal manifestations are common and are often more serious. Problems may occur in other parts of the body including:

NF2 does not have as many outwardly signs as NF1 and in most instances substantial hearing loss is the first sign of possible NF2. The main problem of NF2 is the development of tumours on the brain and spinal cord.

Most tumours in both NF1 and NF2 are non-cancerous (benign). But benign tumour enlargement can interfere with vital functions. It is estimated that a person with NF1 has a 3-15% increased risk for developing cancerous tumours.

What treatment is available?

There is no cure for NF. The main goal of treatment is to monitor its development and intervene when necessary. Healthy children with NF should be followed-up and examined every 6-12 months by a paediatrician.

Neurofibromas that become large and painful can be cut out to reduce the risk of malignancy and other complications.

Genetic counselling and education about NF is important. One concern that should not be overlooked is the risk of isolation or loneliness in people with NF. People with NF are often anxious about future complications and sometimes disfiguring lesions can lead to withdrawal from society.

Targeted molecular therapies show promise for the future treatment of neurofibromatosis.

Related information

Email Newsletter

Would you like to receive DermNet updates by email?

Submit your images

We're seeking high-quality photos of skin diseases.  


Skin lesion photography

Watch Dr Amanda Oakley presenting "Skin lesion photography" at The Australasian Skin Cancer Congress.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter